Genetic & Genomic MedicinemedRxivPreprint
Utilization of targeted resequencing for clinical validation of mutated FANCD2 gene as a promising molecular biomarker of early disease progression in Chronic Myeloid Leukemia
Nawaf Alanazi, Abdulaziz Siyal, Muhammad M. Absar…·Zafar Iqbal
This study identifies a FANCD2 mutation as a specific biomarker for early progression in Chronic Myeloid Leukemia using targeted resequencing and NGS analysis.
DOI 10.1101/2023.12.19.23300103